Sign Out
Zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections (see Precautions and Pharmacology: Pharmacodynamics under Actions): Complicated intra-abdominal infection (cIAI), in combination with metronidazole; Complicated urinary tract infection (cUTI), including pyelonephritis.
Zavicefta is indicated for the treatment of the following infections in adults (see Precautions and Pharmacology: Pharmacodynamics under Actions): Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP).
Treatment of adult patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed as previously mentioned.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Zavicefta and other antibiotics, Zavicefta should be used in combination with an antibacterial agent(s) active against Gram-positive and/or anaerobic pathogens when these are known or suspected to be contributing to the infectious process.
